Our systematic evaluation of 14 previously reported candidate mediators of the effect of BMI on endometrial cancer risk identifies fasting insulin, bioavailable testosterone and SHBG as plausible mediators of this relationship. The gene discussed is INS; the disease is endometrial cancer.